Net margin is calculated as Net Income divided by its Revenue. Acer Medical's Net Income for the
six
months ended in Dec. 2025 was NT$-14.54 Mil. Acer Medical's Revenue for the
six
months ended in Dec. 2025 was NT$29.93 Mil. Therefore, Acer Medical's net margin for the quarter that ended in Dec. 2025 was -48.58%.
The historical rank and industry rank for Acer Medical's Net Margin % or its related term are showing as below:
ROCO:6857'
s Net Margin % Range Over the Past 10 Years
Min: -6622.35 Med: -212.38 Max: -49.43
Current: -49.43
ROCO:6857's Net Margin % is ranked worse than 85.41% of 665
companies
in the Healthcare Providers & Services industry
Industry Median: 2.89
vs ROCO:6857: -49.43
Acer Medical (ROCO:6857) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Acer Medical Net Margin % Related Terms
Acer Medical Net Margin % Historical Data
* Premium members only.
The historical data trend for Acer Medical's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6857 vs VEEV, BTSG, TEM: Net Margin % Comparison
For the Health Information Services subindustry, Acer Medical's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acer Medical Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Acer Medical's Net Margin % distribution charts can be found below:
* The bar in red indicates where Acer Medical's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Acer Medical (ROCO:6857) has a Net Margin % of -48.58% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Acer Medical and its competitors. According to the industry distribution chart, Acer Medical ranks #568 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 85.4%.
Is Acer Medical's Net Margin % too high?
Acer Medical's current Net Margin % is -48.58%. Based on the distribution chart, Acer Medical ranks #568 out of 665 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Acer Medical has a GF Score™ of 52/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Acer Medical's Net Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Acer Medical ranks #568 out of 665 companies for Net Margin %. This places Acer Medical in the lower half of its industry. The industry median Net Margin % is 2.89. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.89, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Acer Medical and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acer Medical's current Net Margin % is -48.58%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acer Medical stock overvalued right now?
Based on GuruFocus' analysis, Acer Medical (ROCO:6857) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$261.37, compared to a current price of NT$92.00 — trading 64.8% below its estimated fair value. The current Net Margin % is -48.58%. Acer Medical's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Acer Medical (ROCO:6857), the current Net Margin % is -48.58% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Acer Medical (ROCO:6857) Overvalued in 2026?
Based on GuruFocus' analysis, Acer Medical stock appears to be undervalued.
The current stock price of NT$92.00 is trading 64.8% below its estimated GF Value™ of NT$261.37.
GuruFocus considers Acer Medical to be Significantly Undervalued.
Key valuation signals for ROCO:6857:
Net Margin %: -48.58%
GF Value™: NT$261.37 vs. price of NT$92.00 (64.8% below fair value)
No single metric tells the full story. See the ROCO:6857 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Acer Medical Inc focuses on improving human health and well-being through artificial intelligence. It focuses on applying artificial intelligence and large data to the area of healthcare. Acer Medical is capable of designing, developing, commercializing, as well as implementing AI solutions in medical institutions.
52GF Score
Get the complete analysis for ROCO:6857
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6857 has been successfully added to your 
